Covid-19

Traws Pharma Inc. (NASDAQ:TRAW) on Wednesday shared interim data from an ongoing randomized, open-label Phase 2 with ratutrelvir, an investigational oral, ritonavir-free Mpro/3CL protease inhibitor. The data demonstrated a differentiated clinical profile in a pre-specified interim analysis in...

The Food and Drug Administration’s top vaccine regulator is pushing new limits on how vaccines win approval. The tougher standards could cloud prospects for vaccine makers and rattle investors in major healthcare and biotech names. Center for Biologics Evaluation and Research Director Vinay...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2. The data from an ongoing Phase 4 clinical trial evaluating the safety, tolerability, and immunogenicity of...

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) reported topline Phase 3 results for their LP.8.1-adapted monovalent COMIRNATY (2025-2026 Formula) in high-risk adults. Among 100 participants, the vaccine generated a ≥4-fold increase in neutralizing antibodies against the LP.8.1 sublineage...

Moderna Inc. (NASDAQ:MRNA) reported on Thursday a first-quarter EPS loss of $(2.52), missing the consensus of $(3.12), down from an EPS loss of $(3.07) a year ago. The COVID-19 vaccine maker reported quarterly sales of $108 million, down from $167 billion a year ago, beating the consensus of $...

On Friday, President Donald Trump's White House launched a new COVID-19 website.  What Happened: The newly launched website sharply criticized the pandemic response by the World Health Organization (WHO), former President Joe Biden, and Dr. Anthony Fauci, who was the nation's top health...

Novavax, Inc. (NASDAQ:NVAX) on Tuesday released preliminary results from the SHIELD-Utah study investigating the effects of systemic and local reactogenicity of COVID-19 vaccine doses in Utah. SHIELD-Utah was a prospective, interventional study conducted at the University...

Pfizer Inc. (NYSE:PFE) shares are trading lower on Wednesday after a Wall Street Journal report revealed U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement. What To Know: The claim, brought forward by British pharmaceutical company GSK, alleges...

Universa Investments hedge fund, led by billionaire investor Mark Spitznagel, posted a 4,144% return in a single quarter during the COVID-19 market crash in early 2020. Here's a look at how he did it.  What To Know: Spitznagel is known as a "doomsday" investor who correctly predicted the Great...

On Monday, the FDA declined Invivyd, Inc.’s (NASDAQ:IVVD) request to expand the existing emergency use authorization (EUA) for pre-exposure prophylaxis of COVID-19 EUA for Pemgarda (pemivibart) for mild-to-moderate COVID-19 in adults and adolescents who have moderate-to-severe...

On Monday, Invivyd Inc. (NASDAQ:IVVD) shares rallied on the heels of a new data report involving a COVID-19 treatment. The company is conducting an ongoing Phase 1/2 trial of VYD2311, a monoclonal antibody (mAb) candidate. A formal estimate of in vivo half-life is not yet available for VYD2311...

Robert F. Kennedy, Jr. will begin Senate confirmation hearings on Wednesday as President Donald Trump's pick to lead the Department of Health and Human Services.  What To Know: If confirmed by the Senate, Kennedy would oversee the National Institutes of Health, the Food and Drug Administration...

The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses nationwide.  The Details: The Louisiana Department of Health said the patient, who was over the age...

A teenager in British Columbia is in critical condition after contracting what is believed to be Canada's first human case of the bird flu. The teen, previously healthy with no underlying conditions, has rapidly deteriorated due to avian influenza, health officials announced this week. Provincial...

On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade Ark Invest removed 49,922 shares of Moderna Inc. (NASDAQ:MRNA) from its ARK Genomic Revolution ETF (BATS:ARKG) on Wednesday. The trade is estimated to be...